{"nct_id":"NCT05361395","title":"First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-09","start_date":"2022-08-24","start_date_type":"ACTUAL","primary_completion_date":"2028-08-28","primary_completion_date_type":"ESTIMATED","completion_date":"2028-08-28","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["AMGN"]}